BioSolutions Consulting bridges innovation and execution. Our expertise lies in designing and optimizing the preclinical strategies that set the stage for clinical success. From advanced lab setup to cutting-edge assay development and optimization, target identification & biomarker validation, we help you ask the right questions, choose the right models, and generate meaningful data.
The success of any therapeutic candidate in the clinic starts with the right lab setup. We specialize in helping you select or develop in vitro and in vivo models that reflect real-world biology and deliver predictive, meaningful translatable results. With deep experience in experimental design, BioSolutions Consulting ensures your preclinical strategy is built to inform, not just perform.
Off-the-shelf assays often fail when biology becomes complex. Whether you need to optimize existing assays or develop novel systems, we help you get closer to in vivo reality. From fully humanized 3D organoids to organ-on-chip platforms and bioprinted models, we’ll guide you in choosing and implementing the right tools to improve relevance, reproducibility, and insight.
Moving from preclinical to clinical requires the deep understanding of mechanism of action (MOA), proof of target engagement, efficacy and safety. We help identify and validate key targets and biomarkers from a range of biological samples, including tissue, plasma, and cell-based systems. Using state-of-the-art technologies and a strategic approach, we ensure your targets and biomarkers are not just detectable, but meaningful.